Meadow Creek Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $296K | Buy |
5,654
+440
| +8% | +$23K | 0.01% | 897 |
|
|
2019
Q2 | $252K | Buy |
5,214
+66
| +1% | +$3.19K | 0.01% | 959 |
|
|
2019
Q1 | $260K | Hold |
5,148
| – | – | 0.01% | 927 |
|
|
2018
Q4 | $305K | Buy |
5,148
+22
| +0.4% | +$1.3K | 0.01% | 810 |
|
|
2018
Q3 | $337K | Buy |
5,126
+22
| +0.4% | +$1.45K | 0.01% | 878 |
|
|
2018
Q2 | $258K | Hold |
5,104
| – | – | 0.01% | 902 |
|
|
2018
Q1 | $269K | Buy |
5,104
+638
| +14% | +$33.6K | 0.01% | 887 |
|
|
2017
Q4 | $208K | Buy |
4,466
+770
| +21% | +$35.9K | ﹤0.01% | 979 |
|
|
2017
Q3 | $150K | Buy |
3,696
+1,034
| +39% | +$42K | ﹤0.01% | 1022 |
|
|
2017
Q2 | $90K | Buy |
2,662
+1,342
| +102% | +$45.4K | ﹤0.01% | 1135 |
|
|
2017
Q1 | $38K | Sell |
1,320
-1,276
| -49% | -$36.7K | ﹤0.01% | 1209 |
|
|
2016
Q4 | $85K | Buy |
+2,596
| New | +$85K | ﹤0.01% | 978 |
|